SCP
DNA icon

Sender Company & Partners’s Ginkgo Bioworks DNA Stock Holding History

Sender Company & Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,723
Closed -$332K – 501
2025
Q2 		$312K Buy
+27,723
New +$215K 0.09% 197

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sender Company & Partners's DNA Position: Q3 2025 in Review

Sender Company & Partners sold out of Ginkgo Bioworks (DNA) in Q3 2025, closing a stake of 27,723 shares — an estimated $332K sold.

Sender Company & Partners first reported a position in DNA in Q2 2025 and held it in 1 quarter. The position peaked at $312K in Q2 2025. 173 funds tracked by Wall St. Rank hold DNA as of Q3 2025.

  • Sender Company & Partners reported no remaining Ginkgo Bioworks position as of Q3 2025 after selling out during the quarter.
  • Sender Company & Partners sold 27,723 Ginkgo Bioworks shares in Q3 2025, an estimated $332K.
  • Sender Company & Partners first reported a position in Ginkgo Bioworks in Q2 2025 and held it in 1 quarter.
  • Sender Company & Partners's Ginkgo Bioworks position peaked at $312K in Q2 2025.
  • 173 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2025.

Based on Sender Company & Partners's 13F filing for Q3 2025, filed 17 Nov 2025.